Ostarine (MK-2866) Tablets

Available in 25mg Tablets (100 Count Bottle)

The Selective Anabolic Agent | Muscle Preservation & Osteo-Support

The 4Balance Codex: The Tissue-Specific Modulator. A non-steroidal Selective Androgen Receptor Modulator designed to promote lean muscle hypertrophy and enhance bone mineral density with minimal systemic androgenic impact.

Product Overview

Ostarine, also known as MK-2866 or Enobosarm, is one of the most extensively studied Selective Androgen Receptor Modulators (SARMs) in existence. It was developed to treat conditions such as muscle wasting (cachexia) and osteoporosis without the undesirable side effects associated with traditional anabolic steroids.

Unlike non-selective androgens, Ostarine exhibits a high affinity for androgen receptors in specific tissues. 4Balance Peptides offers this premier research agent in precise, laboratory-grade 25mg tablets, providing a convenient and accurate format for consistent administration in long-term research protocols.

Mechanism of Action: Tissue-Selective Anabolism

Ostarine’s primary value in research stems from its unique mechanism of action, which allows for targeted anabolic effects:

1. Selective Androgen Receptor Binding: Ostarine binds to the androgen receptor (AR) with high affinity and selectivity. It acts as a full agonist in skeletal muscle and bone tissue, stimulating anabolic pathways, while having significantly reduced androgenic activity in other organs like the prostate and skin.

2. Muscle Hypertrophy & Anti-Catabolism: By binding to ARs in muscle tissue, Ostarine stimulates protein synthesis and increases lean body mass. Clinical trials have demonstrated its ability to increase total lean body mass and improve physical function in populations suffering from muscle wasting conditions, such as cancer cachexia and age-related sarcopenia.

3. Osteo-Anabolic Effects: Ostarine has been shown to have positive effects on bone. It increases bone mineral density (BMD) and bone mechanical strength by stimulating bone formation and reducing bone resorption, making it a compound of significant interest in osteoporosis research.

4. Body Recomposition: In addition to building muscle, research indicates that Ostarine can influence lipid metabolism, leading to a reduction in fat mass. This dual action of increasing lean muscle while simultaneously reducing fat makes it a prime candidate for "body recomposition" studies.

Primary Research Applications

In the 4Balance Research Array, Ostarine is a foundational agent for studies focused on musculoskeletal health and metabolism:

• Muscle Wasting Conditions: Investigating its efficacy in counteracting catabolic states caused by chronic illness, aging (sarcopenia), or immobility.

• Osteoporosis & Bone Health: Studying its potential as a therapy to increase bone density and reduce fracture risk.

• Body Composition & Metabolism: Exploring its synergistic effects on muscle protein synthesis and adipose tissue oxidation for overall physique alteration.

• Recovery & Rehabilitation: Researching its role in accelerating recovery from injuries by promoting tissue repair.

Technical Specifications

• Compound Name: Ostarine (MK-2866 / Enobosarm)

• Format: Oral Tablets

• Concentration: 25mg per Tablet

• Quantity: 100 Tablets

• Purity: ≥99% (HPLC Verified)

• Storage: Store at room temperature, away from direct light and moisture.

DISCLAIMER: FOR LABORATORY RESEARCH USE ONLY. This product is a laboratory chemical intended strictly for in-vitro and in-vivo research and development. It is not a drug, dietary supplement, or treatment for any medical condition. NOT for human consumption, veterinary use, or therapeutic application. Bodily introduction of any kind is strictly prohibited by law. Buyer assumes all responsibility for applicable regulations and appropriate use in a research setting.